Dutarget Tablet (Dutasteride)

Adult dose

The recommended dose of this medicine is 1 tablet (0.5mg) once daily. Swallow this medicine whole without chewing or splitting it. This medicine may be taken with or without food. No dose adjustment is necessary in patients with renal impairment or elderly patients. The recommended dose of this medicine in patients with hepatic impairment has not been established because there are no data on its administration to patients with hepatic impairment.

This medication must not be handled or taken by women, especially those who are pregnant or may become pregnant. This is because the drug can be absorbed through the skin, posing a risk of birth defects in male fetuses. Furthermore, precautions should be taken to ensure that children do not touch broken or crushed pieces of this medication. This medication is not to be administered to women and children under 18 years of age. Also, individuals with an allergy to this medication or its ingredients should not use it. Patients with a genetically specific lactase deficiency should also avoid this medication. Adult men planning to conceive should use this medication carefully under the guidance of a physician, as it may affect reproductive ability. Patients with high residual urine volume or severe urinary reduction symptoms should be observed closely for the risk of urinary retention when using this medication. Patients with liver dysfunction should also use this medication with caution. Care should be taken when taken with strong CYP3A4 inhibitors, as the drug concentration may increase. During the administration of this medication, sexual dysfunction such as erectile dysfunction, decreased libido, or ejaculation disorders may occur, and gynecomastia may develop in some patients. These adverse reactions may persist even after discontinuation of the medication. This medication is used for the treatment of benign prostatic hyperplasia and androgenetic alopecia, and it has been reported that long-term use does not increase the incidence of sexual dysfunction or breast disorders. However, there may be a slight increase in the risk of high-grade prostate cancer during the course of this medication, necessitating regular prostate cancer screening. Patients taking this medication should refrain from donating blood and must wait at least 6 months after the last dose before they can donate blood. This medication is known to have no effect on driving or operating machinery. In case of overdose, no specific antidote exists, so appropriate supportive treatment should be received according to symptoms, and consideration should be given to the long half-life of this medication. This medication should be kept out of reach of children and stored in its original container to prevent misuse or deterioration.

• Erectile dysfunction
• decreased libido
• ejaculation disorders
• gynecomastia
• headache
• gastrointestinal discomfort and pain
• sexual dysfunction
• breast disorders
• dizziness
• rash

This medication may be sensitive to air or moisture, so it must be stored in a tightly closed container. It is recommended to maintain a storage temperature between 1 to 30 degrees Celsius at room temperature. Avoid storing in places that are too hot or too cold.

Appearance

Pale yellow round film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTPX3)]